{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-021567","form_type":"8-K","ticker":"PPCB","cik":"0001517681","company_name":"Propanc Biopharma, Inc.","filed_at":"2025-11-10T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.611081+00:00","generated_at":"2026-05-16T22:21:47.550745+00:00","sec_items":["3.02","5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Propanc Biopharma closes $1.0M private placement of Series C Preferred Stock to Hexstone Capital","bullets":["Hexstone purchased 100 Series C Preferred shares at $10,000 each plus a warrant for up to 9,900 additional shares; total cash $1,000,099.","Series C Preferred convertible into common at the lesser of $5.00 fixed price or 85% of lowest trading price over a specified period.","Board authorized up to 9,900 shares of Series C Preferred via Certificate of Designation filed November 4, 2025.","Securities issued under private placement exemption per Section 4(a)(2) and Regulation D."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-021567","json":"https://secwatch.observer/filing/0001493152-25-021567.json","markdown":"https://secwatch.observer/filing/0001493152-25-021567.md","text":"https://secwatch.observer/filing/0001493152-25-021567.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1517681/000149315225021567/0001493152-25-021567-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1517681/000149315225021567/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T22:21:47.550745+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0fa65731fb3f40b7b5f0dea81f0697ce1cf58475","claim":"Propanc Biopharma, Inc.: Filed Certificate of Designation creating Series C Preferred Stock as an amendment to the Certificate of Incorporation (effective 2025-11-04).","evidence_excerpt":"On November 4, 2025, the Company amended its Certificate of Incorporation and filed a Certificate of Designation with the Delaware Secretary of State that authorized the issuance of up to 9,900 shares of a new series of preferred stock, par value $0.01 per share, designated as “Series C Preferred Stock” for which the Board established the rights, preferences and limitations thereof.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1517681/000149315225021567/0001493152-25-021567-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2025-11-04"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}